HLA-Mismatched Related and Unrelated HCT Are Feasible Options for Patients with CGD without Matched Donors: A Primary Immune Deficiency Treatment Consortium Report
Document Type
Conference Proceeding
Publication Date
2-3-2026
Publication Title
Transplantation and Cellular Therapy
Abstract
Tandem Meetings of ASTCT and CIBMTR, February 4-7, 2026, Salt Lake City, UT
First Page
S38
Last Page
S39
Volume
32
Issue
2, Supplement
Rights
© 2025 Published by Elsevier Inc.
Recommended Citation
Murguía-Favela, L.; Arnold, D.E.; Logan, B.R.; Chunara, F.; Griffith, L.M.; Marsh, R.A.; Parikh, S.; Grunebaum, E.; Chellapandian, D.; Mallhi, K.; Deal, C.L.; Kapoor, N.; Heimall, J.R.; Chen, K.; Bednarski, J.J.; Chandra, S.; McKinney, C.; O'Reilly, R.J.; Yu, Lolie C.; Broglie, L.; Dávila Saldaña, B.J.; Ebens, C.L.; Joshi, A.; Kapadia, M.; Martinez, C.A.; Miller, H.K.; Wright, N.A.; Falcone, E.L.; Burroughs, L.M.; and al, et, "HLA-Mismatched Related and Unrelated HCT Are Feasible Options for Patients with CGD without Matched Donors: A Primary Immune Deficiency Treatment Consortium Report" (2026). School of Medicine Faculty Publications. 5172.
https://digitalscholar.lsuhsc.edu/som_facpubs/5172
10.1016/j.jtct.2025.12.062
Comments
Abstract #44